Update shared on 27 Nov 2025
Analysts have maintained Elkem's fair value price target at NOK 29.80, citing stable underlying financial metrics and a slightly reduced discount rate as the basis for their decision.
What's in the News
- Elkem ASA launched SILBIONE LSR Select EC 70, a next-generation medical-grade liquid silicone rubber designed for wearable and diagnostic devices. The material offers high electrical conductivity, certified biocompatibility, and improved process control for precision healthcare applications (Key Developments).
- SILBIONE LSR Select EC 70 features resistivity below 10 ohm-centimeters. This makes it suitable for use in flexible electronics, advanced sensors, and prosthetics. It has passed ISO 10993-5 and ISO 10993-10 safety tests, confirming its suitability for medical applications (Key Developments).
- Elkem ASA announced a partial curtailment of ferrosilicon production at its plants in Rana, Norway, and Iceland due to weak market demand in Europe and increasing uncertainty related to an EU investigation into potential import safeguard measures (Key Developments).
- The curtailment may lead to temporary employee layoffs and is intended to help reduce inventories and support improved market balance in the steel industry (Key Developments).
Valuation Changes
- Consensus Analyst Price Target remains unchanged at NOK 29.80.
- Discount Rate has decreased modestly from 8.02% to 7.94%.
- Revenue Growth projection is steady at 36.49%.
- Net Profit Margin is largely unchanged and remains at approximately 6.05%.
- Future P/E ratio has edged down slightly from 9.16x to 9.14x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.